| Literature DB >> 36196141 |
Monique Gonçalves Dos Santos Novelino Ramos1, Sabrina Destri Emmerick Campos1, Marcelo Abrahão Strauch2, Leila Cardozo Ott3, Daniel de Barros Macieira1, Nayro Xavier de Alencar1, Daniel Augusto Barroso Lessa1.
Abstract
Indisputably, the use of antivenoms for the treatment of snakebite envenoming is beneficial for the victims. However, there are few studies addressing the effect of long-term hyperimmunization in inoculated horses. It is known that the injection of snake venoms and adjuvants leads to local and systemic reactions in horses, but little is known about the response of inflammatory proteins. The aim of this study was to evaluate serum proteins and the electrophoretic profile of horses undergoing crotalid venom hyperimmunization. Twenty horses were divided into two groups: an inoculated group, comprising ten horses that were already being used for production of a Crotalus sp. antivenom, and a control group, comprising ten animals that had never been used for hyperimmunization. All animals were clinically healthy and without laboratory abnormalities. Total protein and albumin concentrations were measured in serum. Serum globulins were obtained by calculation. Plasma fibrinogen estimates were determined by the heat precipitation method. Serum proteinograms were obtained using agarose gel electrophoresis. The results revealed a significant increase in the concentrations of total serum proteins, globulins, and β-globulins in the inoculated group, exceeding the reference values. There were slight increases in the α-1- and α-2-globulin subfractions in serum-producing horses, with no statistical significance. We also observed that horses used to produce hyperimmune plasma developed hypoalbuminemia, although the decrease in albumin production was not statistically significant. Our findings suggest that the continuous use of horses to produce crotalid antivenom may lead to a chronic inflammatory stimulus, with changes in plasma levels of inflammatory proteins. ©2022 The Japanese Society of Equine Science.Entities:
Keywords: hyperimmune plasma; inflammation; proteinogram
Year: 2022 PMID: 36196141 PMCID: PMC9522620 DOI: 10.1294/jes.33.31
Source DB: PubMed Journal: J Equine Sci ISSN: 1340-3516
Mean ± standard deviation and P-values for the serum proteinogram, fibrinogen and protein electrophoresis of horses never used in immunization programs (control group) and horses used for the production of anticrotalic hyperimmune plasma (inoculated group).
| Parameter | Reference value1 | Control group (n=10) | Inoculated group (n=10) | |
|---|---|---|---|---|
| Mean2 ± SD | ||||
| Serum proteinogram | ||||
| Total protein (g/d | 5.2–7.9 | 6.65A ± 0.53 | 8.20B ±0.56 | 0.000 |
| Albumin (g/d | 2.6–3.7 | 2.43A ± 0.32 | 2.18A ± 0.52 | 0.215 |
| Globulins (g/d | 2.62–4.04 | 4.22A ± 0.45 | 6.02B ± 1.03 | 0.000 |
| Protein electrophoresis | ||||
| Albumin (g/d | 2.6–3.7 | 2.66A ± 0.55 | 2.17A ± 0.44 | 0.410 |
| Alpha 1 globulin (g/d | 0.06–0.7 | 0.29A ± 0.14 | 0.37A ± 0.12 | 0.147 |
| Alpha 2 globulin (g/d | 0.3–1.3 | 0.37A ± 0.12 | 0.59A ± 0.22 | 0.130 |
| Beta globulin (g/d | 0.7–2.5 | 2.16A ± 0.37 | 2.99B ± 0.57 | 0.001 |
| Gama globulin (g/d | 0.55–1.9 | 1.53A ± 0.37 | 1.58A ± 0.32 | 0.756 |
| Fibrinogen (mg/d | 100–400 | 380.00A ± 147.57 | 300.00A ± 141.42 | 0.232 |
1According to Kaneko, Harvey and Bruss (2008) [9]. 2Different letters (A/B) in the same line indicate a statistically significant difference (P<0.05) by the independent samples t-test. SD: standard deviation.